InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,744.50
(
-0.23%
)
Post# of 251715
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1727
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: biotech jim post# 171379

Tuesday, 12/17/2013 1:21:15 AM

Tuesday, December 17, 2013 1:21:15 AM

Post# of 251715

This result just shows how complicated the memory enhancement business (in man) really is.




I agree. There are plenty of mice crawling around with enhanced memory. TC-5619 had been looked at in AD in a prior small clinical study. The results in Schizophrenia have sealed the compounds fate. The private company you referenced was Envivo and I feel the results are worth noting. ABBV and BMY are both working on compounds targeting A7.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up